|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01498 PURAPHARM
Nominal 
0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -11.404% | -10.819% | -9.446% | 2.442% | -17.787% |
| ROAE (%) | -51.555% | -36.437% | -26.692% | 7.258% | -49.172% |
| Return on Capital Employed (%) | -38.875% | -34.240% | -22.547% | 4.051% | -38.970% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 53.244% | 58.630% | 64.184% | 61.472% | 57.314% |
| EBITDA Margin (%) | -6.504% | -10.448% | -6.123% | 18.979% | -17.644% |
| Pre-tax Profit Margin (%) | -25.147% | -26.599% | -17.767% | 6.683% | -31.061% |
| Net Profit Margin (%) | -26.073% | -26.829% | -18.478% | 5.269% | -32.658% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 0.612 X | 0.730 X | 0.918 X | 1.027 X | 0.935 X |
| Quick Ratio (X) | 0.305 X | 0.471 X | 0.669 X | 0.722 X | 0.621 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 81.843% | 74.590% | 66.700% | 62.777% | 70.372% |
| Total Debt / Total Assets (%) | 50.330% | 49.499% | 44.114% | 38.129% | 44.307% |
| Net Debt / Total Assets (%) | 47.946% | 42.039% | 39.166% | 31.480% | 38.742% |
| Total Debt / Shareholders' Funds (%) | 277.200% | 194.804% | 132.474% | 102.434% | 149.544% |
| Long Term Debt / Shareholders' Funds (%) | 67.070% | 28.848% | 27.655% | 41.704% | 51.425% |
| Net Debt / Shareholders' Funds (%) | 264.066% | 165.445% | 117.614% | 84.570% | 130.763% |
| Net Cash / (Debt) ($) | (404.644M) | (427.326M) | (472.288M) | (432.710M) | (473.524M) |
| Net Cash / (Debt) per share ($) | (1.022) | (1.079) | (1.196) | (1.096) | (1.699) |
| Total Debt / Capital Employed (%) | 155.665% | 143.312% | 98.411% | 66.963% | 92.862% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | 2.499 X | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 333.837 Day | 333.188 Day | 267.419 Day | 299.892 Day | 254.926 Day |
| Receivables Turnover (Day) | 95.425 Day | 160.181 Day | 133.621 Day | 137.148 Day | 136.739 Day |
| Payables Turnover (Day) | 127.521 Day | 113.471 Day | 83.012 Day | 102.598 Day | 83.447 Day |
| Remarks: | Real time quote last updated: 25/11/2024 07:44 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -18,686,000 |
| %Change | -50.402% |
| EPS / (LPS) | HKD -0.047 |
| NBV Per Share ($) | HKD 0.330 |